News
Sosei Group gains marketing approval for PIVLAZ 150 mg in South Korea
Sosei Group Corporation's (Sosei Heptares') PIVLAZ (clazosentan sodium) 150 mg has received marketing approval from the Ministry of Food and Drug Safety (MFDS) in...
AbbVie to acquire Cerevel Therapeutics to strengthen neuroscience pipeline
AbbVie has announced a definitive agreement to acquire Cerevel Therapeutics and its neuroscience pipeline of multiple clinical-stage and preclinical candidates with potential across several...
Absci and AstraZeneca to advance AI-driven oncology candidate
Absci Corporation is collaborating with AstraZeneca to deliver an AI-designed antibody against an oncology target.
The collaboration combines Absci’s Integrated Drug Creation platform with AstraZeneca’s...
